Pulse Biosciences, Inc.
PLSE· Nasdaq
Filed Mar 14, 2019 · 10-K · 73 days after period end · 0001625101-19-000008
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$8.95M | -$8.70M | -$2.81M | -$1.02M |
| EPS Diluted | -$0.51 | -$0.53 | -$0.21 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 14, 2019 · 73 d after period end